PC
EVH icon

PA Capital’s Evolent Health EVH Stock Holding History

PA Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,251
Closed -$156K – 171
2019
Q4 		$156K Buy
+17,251
New +$140K 0.14% 121

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

PA Capital's EVH Position: Q1 2020 in Review

PA Capital sold out of Evolent Health (EVH) in Q1 2020, closing a stake of 17,251 shares — an estimated $156K sold.

PA Capital first reported a position in EVH in Q4 2019 and held it in 1 quarter. The position peaked at $156K in Q4 2019. 154 funds tracked by Wall St. Rank hold EVH as of Q1 2020.

  • PA Capital reported no remaining Evolent Health position as of Q1 2020 after selling out during the quarter.
  • PA Capital sold 17,251 Evolent Health shares in Q1 2020, an estimated $156K.
  • PA Capital first reported a position in Evolent Health in Q4 2019 and held it in 1 quarter.
  • PA Capital's Evolent Health position peaked at $156K in Q4 2019.
  • 154 funds tracked by Wall St. Rank held Evolent Health as of Q1 2020.

Based on PA Capital's 13F filing for Q1 2020, filed 11 May 2020.